SCR-LIP-000772 · Claim · machine-readable JSON →
Limb volume in lipedema appears stable in most patients over several years, with volume change associated with changes in body mass index.
General proposition consolidated from 1 earlier single-paper claims; each study's own result is shown as its finding.
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- low (GRADE)
- Evidence
- 1 source(s)
- Answers
- 1 question(s)
- Dates
- 2026-11-20 → 2026-11-20
Structured evidence, machine-compiled — not a verdict.
Evidence over time
Evidence (1)
- Is lipedema a progressive disease? (2025) ✓ verified — consistent · cohort · 2025 · risk of bias: high · reading confidence: high
“Stability was observed in 62% of the patients, progression in 28%, and improvement in 10%.”
In 100 patients over 4.6 years, 62% stable, 28% progressed, 10% improved (mean volume change 2.8%); change associated with BMI and waist-to-height increases.
The cohort found lipedema generally stable, with volume progression driven by weight gain (BMI/WHtR) rather than disease chronicity or stage; lymphoscintigraphic abnormalities were not associated with progression, arguing against inherent pWhy this risk of bias: full-text methodological appraisal (6)
Each point was checked against the full text and is shown with the verbatim passage. Positional or interpretive points were excluded. AI full-text appraisal (Claude), each point checked against the PDF · 2026-11-17
- Not an untreated natural history: most patients were on active conservative treatment, although the paper presents itself as a natural-history study.
“A total of 76% of the patients wore the compression garments prescribed by the doctor and 66% carried out [physical exercise]” - Selection: only 100 of 195 recruited patients (those with two volume measurements) were analysed, and liposuction history was an exclusion criterion, so patients who progressed to surgery may be missing.
“From the 195 patients with lipedema recruited in our prospective cohort from September 2012 to September 2023, those who had at least two volume measurements” - The volume change is taken at the first follow-up (median 3.1 years, SD 1.9), not at the 4.6-year median in the abstract, and the fixed ±10% cut-off is not adjusted for time.
“first follow up had a median of 3.1 years (SD: 1.9) after baseline” - The mean volume change has a confidence interval above zero (net increase), and 28% progressed versus 10% improved; 'stability in 62%' depends on the chosen cut-off.
“The mean PVC was 2.8% (95% CI: 0.6–5.0)” - The case definition requires pain or discomfort, so painless lipedema is excluded by design.
“associated with pain or discomfort in LL” - Lymphatic involvement was frequent in the same cohort (relevant to the lipedema–lymphedema question).
“Lymphoscintigraphic alterations (n = 76) 35/76 (46.1%)”
- Not an untreated natural history: most patients were on active conservative treatment, although the paper presents itself as a natural-history study.
Context (PECO)
Answers these questions
Gaps & caveats
Change log
- 2026-11-20 — created_by_consolidation · general proposition consolidated from SQ-LIP-000039